{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:36:21Z","timestamp":1775266581757,"version":"3.50.1"},"reference-count":34,"publisher":"Galenos Yayinevi","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjps"],"published-print":{"date-parts":[[2024,2,20]]},"DOI":"10.4274\/tjps.galenos.2024.80552","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T06:45:50Z","timestamp":1708411550000},"page":"0-0","source":"Crossref","is-referenced-by-count":2,"title":["Protective Effect of Rosmarinic Acid and Epigallocatechin Gallate Against Doxorubicin-\u0130nduced Cytotoxicity and Genotoxicity on CHO-K1 Cells"],"prefix":"10.4274","volume":"0","author":[{"given":"Sinem","family":"Helvacioglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed","family":"Hamitoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ecem","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senay","family":"Vural Korkut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aylin","family":"Yaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3892\/mco.2014.250","article-title":"Second malignancies after breast cancer: The impact of adjuvant therapy","volume":"2","author":"Dong","year":"2014","unstructured":"1. Dong C, Chen L. Second malignancies after breast cancer: The impact of adjuvant therapy. Mol Clin Oncol. 2014;2:331-336.","journal-title":"Mol Clin Oncol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1534735406298302","article-title":"Modulation of doxorubicin-induced genotoxicity by Aegle marmelos in mouse bone marrow: a micronucleus study","volume":"6","author":"Venkatesh","year":"2007","unstructured":"2. Venkatesh P, Shantala B, Jagetia GC, Rao KK, Baliga MS. Modulation of doxorubicin-induced genotoxicity by Aegle marmelos in mouse bone marrow: a micronucleus study. Integr Cancer Ther. 2007;6:42-53.","journal-title":"Integr Cancer Ther"},{"key":"ref2","unstructured":"3. Nunes S, Madureira AR, Campos D, Sarmento B, Gomes AM, Pintado M, Reis F. Therapeutic and nutraceutical potential of rosmarinic acid-cytoprotective properties and pharmacokinetic profile. Crit Rev Food Sci Nutr. 2017;57:1799-1806."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0163-7258(00)00086-3","article-title":"Basis for effective combination cancer chemotherapy with antimetabolites","volume":"87","author":"Peters","year":"2000","unstructured":"4. Peters GJ, van der Wilt CL, van Moorsel CJ, Kroep JR, Bergman AM, Ackland SP. Basis for effective combination cancer chemotherapy with antimetabolites. Pharmacol Ther. 2000;87:227-253.","journal-title":"Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","article-title":"Doxorubicin pathways: pharmacodynamics and adverse effects","volume":"21","author":"Thorn","year":"2011","unstructured":"5. Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, Altman RB. Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics. 2011;21:440-446.","journal-title":"Pharmacogenet Genomics"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges","volume":"10","author":"Zou","year":"2020","unstructured":"6. Zou Z, Tao T, Li H, Zhu X. mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Biosci. 2020;10:31.","journal-title":"Cell Biosci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.3892\/ol.2019.10589","article-title":"Rapamycin enhanced the antitumor effects of doxorubicin in myelogenous leukemia K562 cells by downregulating the mTOR\/p70S6K pathway","volume":"18","author":"Li","year":"2019","unstructured":"7. Li J, Liu W, Hao H, Wang Q, Xue L. Rapamycin enhanced the antitumor effects of doxorubicin in myelogenous leukemia K562 cells by downregulating the mTOR\/p70S6K pathway. Oncol Lett. 2019;18:2694-2703.","journal-title":"Oncol Lett"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12967-016-0814-z","article-title":"PI3K\/AKT\/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma","volume":"14","author":"Babichev","year":"2016","unstructured":"8. Babichev Y, Kabaroff L, Datti A, Uehling D, Isaac M, Al-Awar R, Prakesch M, Sun RX, Boutros PC, Venier R, Dickson BC, Gladdy RA. PI3K\/AKT\/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma. J Transl Med. 2016;14:67.","journal-title":"J Transl Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.mimet.2008.03.002","article-title":"WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line","volume":"73","author":"Ngamwongsatit","year":"2008","unstructured":"9. Ngamwongsatit P, Banada PP, Panbangred W, Bhunia AK. WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line. J Microbiol Methods. 2008;73:211-215.","journal-title":"J Microbiol Methods"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1007\/s00204-021-03164-3","article-title":"Cell survival after DNA damage in the comet assay","volume":"95","author":"Bankoglu","year":"2021","unstructured":"10. Bankoglu EE, Schuele C, Stopper H. Cell survival after DNA damage in the comet assay. Arch Toxicol. 2021;95:3803-3813.","journal-title":"Arch Toxicol"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Reimann H, Bankoglu EE, Stopper H, Hintzsche H. In vitro evaluation of chromosomal damage and DNA strand breaks after treatment with the poppy seed alkaloid thebaine. Mutat Res Genet Toxicol Environ Mutagen. 2021;870-871:503393.","DOI":"10.1016\/j.mrgentox.2021.503393"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/mc.20710","article-title":"Aldosterone induces oxidative stress, oxidative DNA damage and NF-\u03baB-activation in kidney tubule cells","volume":"50","author":"Queisser","year":"2011","unstructured":"12. Queisser N, Oteiza PI, Stopper H, Oli RG, Schupp N. Aldosterone induces oxidative stress, oxidative DNA damage and NF-\u03baB-activation in kidney tubule cells. Mol Carcinog. 2011;50:123-135.","journal-title":"Mol Carcinog"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1757-2215-5-38","article-title":"The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS)","volume":"5","author":"Yaba","year":"2012","unstructured":"13. Yaba A, Demir N. The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS). J Ovarian Res. 2012;5:38.","journal-title":"J Ovarian Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCULATIONAHA.105.568402","article-title":"Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy","volume":"113","author":"Li","year":"2006","unstructured":"14. Li L, Takemura G, Li Y, Miyata S, Esaki M, Okada H, Kanamori H, Khai NC, Maruyama R, Ogino A, Minatoguchi S, Fujiwara T, Fujiwara H. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy. Circulation. 2006;113:535-543.","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.bcp.2007.06.031","article-title":"Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes","volume":"74","author":"Yeh","year":"2007","unstructured":"15. Yeh YC, Lai HC, Ting CT, Lee WL, Wang LC, Wang KY, Lai HC, Liu TJ. Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochem Pharmacol. 2007;74:969-980.","journal-title":"Biochem Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.canlet.2005.10.021","article-title":"Dual function of (-)-epigallocatechin gallate (EGCG) in healthy human lymphocytes","volume":"241","author":"Kanadzu","year":"2006","unstructured":"16. Kanadzu M, Lu Y, Morimoto K. Dual function of (-)-epigallocatechin gallate (EGCG) in healthy human lymphocytes. Cancer Lett. 2006;241:250-255.","journal-title":"Cancer Lett"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1021\/tx000080k","article-title":"New oxidation products of (-)-epigallocatechin gallate and (-)-epigallocatechin from their reactions with peroxyl radicals","volume":"13","author":"Valcic","year":"2000","unstructured":"17. Valcic S, Burr JA, Timmermann BN, Liebler DC. Antioxidant chemistry of green tea catechins. New oxidation products of (-)-epigallocatechin gallate and (-)-epigallocatechin from their reactions with peroxyl radicals. Chem Res Toxicol. 2000;13:801-810.","journal-title":"Chem Res Toxicol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0006-2952(03)00541-0","article-title":"(-)-Epigallocatechin gallate causes oxidative damage to isolated and cellular DNA","volume":"66","author":"Furukawa","year":"2003","unstructured":"18. Furukawa A, Oikawa S, Murata M, Hiraku Y, Kawanishi S. (-)-Epigallocatechin gallate causes oxidative damage to isolated and cellular DNA. Biochem Pharmacol. 2003;66:1769-1778.","journal-title":"Biochem Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jnutbio.2005.10.005","article-title":"Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration","volume":"17","author":"Sutherland","year":"2006","unstructured":"19. Sutherland BA, Rahman RM, Appleton I. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J Nutr Biochem. 2006;17:291-306.","journal-title":"J Nutr Biochem"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/jat.1491","article-title":"Protective effect of rosmarinic acid on V79 cells evaluated by the micronucleus and comet assays","volume":"30","author":"Furtado","year":"2010","unstructured":"20. Furtado RA, de Ara\u00fajo FR, Resende FA, Cunha WR, Tavares DC. Protective effect of rosmarinic acid on V79 cells evaluated by the micronucleus and comet assays. J Appl Toxicol. 2010;30:254-259.","journal-title":"J Appl Toxicol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0300-483X(02)00383-9","article-title":"Antioxidant nutrients and adriamycin toxicity","volume":"180","author":"Quiles","year":"2002","unstructured":"21. Quiles JL, Huertas JR, Battino M, Mataix J, Ram\u00edrez-Tortosa MC. Antioxidant nutrients and adriamycin toxicity. Toxicology. 2002;180:79-95.","journal-title":"Toxicology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.4314\/tjpr.v13i12.10","article-title":"Genoprotective and genotoxic effects of thymoquinone on doxorubicin-induced damage in isolated human leukocytes","volume":"13","author":"Al-Shdefat","year":"2014","unstructured":"22. Al-Shdefat RI, Abd-Elaziz MA, Al-Saikhan FI. Genoprotective and genotoxic effects of thymoquinone on doxorubicin-induced damage in isolated human leukocytes. Trop J Pharm Res. 2014;13:2015-2020.","journal-title":"Trop J Pharm Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1083\/jcb.201003034","article-title":"BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair","volume":"191","author":"Ismail","year":"2010","unstructured":"23. Ismail IH, Andrin C, McDonald D, Hendzel MJ. BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair. J Cell Biol. 2010;191:45-60.","journal-title":"J Cell Biol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2165\/00063030-200115070-00005","article-title":"Silymarin: a review of its clinical properties in the management of hepatic disorders","volume":"15","author":"Wellington","year":"2001","unstructured":"24. Wellington K, Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs. 2001;15:465-489.","journal-title":"BioDrugs"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3390\/antiox11061087","article-title":"Hydroxytyrosol prevents doxorubicin-induced oxidative stress and apoptosis in cardiomyocytes","volume":"11","author":"Sirangelo","year":"2022","unstructured":"25. Sirangelo I, Liccardo M, Iannuzzi C. Hydroxytyrosol prevents doxorubicin-induced oxidative stress and apoptosis in cardiomyocytes. Antioxidants (Basel). 2022;11:1087.","journal-title":"Antioxidants (Basel)"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","unstructured":"26. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274-293.","journal-title":"Cell"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ceb.2011.09.003","article-title":"mTOR signaling in disease","volume":"23","author":"Dazert","year":"2011","unstructured":"27. Dazert E, Hall MN. mTOR signaling in disease. Curr Opin Cell Biol. 2011;23:744-755.","journal-title":"Curr Opin Cell Biol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00394-013-0516-8","article-title":"Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF\/SMAD, PI3 K\/Akt\/FoxO1, and NF-kappa B pathways","volume":"53","author":"Xiao","year":"2014","unstructured":"28. Xiao J, Ho CT, Liong EC, Nanji AA, Leung TM, Lau TY, Fung ML, Tipoe GL. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF\/SMAD, PI3 K\/Akt\/FoxO1, and NF-kappa B pathways. Eur J Nutr. 2014;53:187-199.","journal-title":"Eur J Nutr"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbrc.2011.02.010","article-title":"Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase\/mTOR inhibitor","volume":"406","author":"Van Aller","year":"2011","unstructured":"29. Van Aller GS, Carson JD, Tang W, Peng H, Zhao L, Copeland RA, Tummino PJ, Luo L. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase\/mTOR inhibitor. Biochem Biophys Res Commun. 2011;406:194-199.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"6437467","DOI":"10.1155\/2017\/6437467","article-title":"Insights for Oxidative Stress and mTOR signaling in myocardial ischemia\/reperfusion injury under diabetes","volume":"2017","author":"Zhao","year":"2017","unstructured":"30. Zhao D, Yang J, Yang L. Insights for Oxidative Stress and mTOR signaling in myocardial ischemia\/reperfusion injury under diabetes. Oxid Med Cell Longev. 2017;2017:6437467.","journal-title":"Oxid Med Cell Longev"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Aramburu J, Ortells MC, Tejedor S, Buxad\u00e9 M, L\u00f3pez-Rodr\u00edguez C. Transcriptional regulation of the stress response by mTOR. Sci Signal. 2014;7:re2.","DOI":"10.1126\/scisignal.2005326"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"18988","DOI":"10.1074\/jbc.M117.807735","article-title":"Thioredoxin-1 maintains mechanistic target of rapamycin (mTOR) function during oxidative stress in cardiomyocytes","volume":"292","author":"Oka","year":"2017","unstructured":"32. Oka SI, Hirata T, Suzuki W, Naito D, Chen Y, Chin A, Yaginuma H, Saito T, Nagarajan N, Zhai P, Bhat S, Schesing K, Shao D, Hirabayashi Y, Yodoi J, Sciarretta S, Sadoshima J. Thioredoxin-1 maintains mechanistic target of rapamycin (mTOR) function during oxidative stress in cardiomyocytes. J Biol Chem. 2017;292:18988-19000.","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.tiv.2003.12.012","article-title":"Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties","volume":"18","author":"Azam","year":"2004","unstructured":"33. Azam S, Hadi N, Khan NU, Hadi SM. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties. Toxicol In Vitro. 2004;18:555-561.","journal-title":"Toxicol In Vitro"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.phymed.2016.09.010","article-title":"Rosmarinic acid stimulates liver regeneration through the mTOR pathway","volume":"23","author":"Lou","year":"2016","unstructured":"34. Lou K, Yang M, Duan E, Zhao J, Yu C, Zhang R, Zhang L, Zhang M, Xiao Z, Hu W, He Z. Rosmarinic acid stimulates liver regeneration through the mTOR pathway. Phytomedicine. 2016;23:1574-1582.","journal-title":"Phytomedicine"}],"container-title":["Turkish Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T06:47:55Z","timestamp":1737010075000},"score":1,"resource":{"primary":{"URL":"https:\/\/turkjps.org\/articles\/doi\/tjps.galenos.2024.80552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":34,"journal-issue":{"issue":"0","published-online":{"date-parts":[[2024,2,20]]},"published-print":{"date-parts":[[2024,2,20]]}},"URL":"https:\/\/doi.org\/10.4274\/tjps.galenos.2024.80552","relation":{},"ISSN":["1304-530X","2148-6247"],"issn-type":[{"value":"1304-530X","type":"print"},{"value":"2148-6247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]}}}